SCHEMBL5834

SCHEMBL5834

CCCOC[C@]1(O)CC[C@]2(CCN(c3ccc(CC)cc3)C2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.37
CYP3A4 P08684 9/20 0.35
CYP2C9 P11712 4/20 0.35
CYP1A2 P05177 4/20 0.35
ALDH1A1 P00352 4/20 0.35
USP2 O75604 4/20 0.35
HSD17B10 Q99714 4/20 0.35
HIF1A Q16665 2/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 5/20 0.35
TSHR P16473 2/20 0.35
LIPE Q05469 2/20 0.35
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CYP2D6 P10635 1/20 0.34
ITGB3 P05106 3/20 0.34
ITGA2B P08514 3/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5667 0.90 CYP3A4 (0.37) S1PR1CYP3A4CYP2C9CYP1A2ALDH1A1
SCHEMBL5655 0.86 CYP3A4 (0.40) S1PR1CYP3A4CYP2C9CYP1A2ALDH1A1
SCHEMBL5474 0.85 ITGB3 (0.36) CYP3A4CYP2C9CYP1A2ALDH1A1USP2
SCHEMBL5680 0.81 CYP3A4 (0.43) CYP3A4CYP2C9CYP1A2ALDH1A1USP2
SCHEMBL5843 0.75 ITGB3 (0.37) CYP3A4CYP2C9CYP1A2ALDH1A1USP2
SCHEMBL5639 0.75 S1PR1 (0.41) S1PR1CYP3A4CYP2C9CYP1A2ALDH1A1
SCHEMBL9998 0.74 LIPE (0.60) S1PR1LIPEITGB3ITGA2B
SCHEMBL9997 0.74 LIPE (0.60) S1PR1LIPEITGB3ITGA2B
SCHEMBL13849672 0.71 KDM4E (0.42) CYP3A4CYP2C9CYP1A2ALDH1A1USP2
SCHEMBL5611 0.71 CYP3A4 (0.40) CYP3A4CYP2C9CYP1A2ALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP claimed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO claimed